osimertinib 80 MG Oral Tablet [Tagrisso]

RxCUI: 1721583
RxNorm name: osimertinib 80 MG Oral Tablet [Tagrisso]
Display name: osimertinib 80 MG Oral Tablet [Tagrisso]
Full name: osimertinib 80 MG Oral Tablet [Tagrisso]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TAGRISSO	OSIMERTINIB	AstraZeneca Pharmaceuticals LP	5e81b4a7-b971-45e1-9c31-29cea8c87ce7	2024-09-25	Warnings, Adverse reactions	Exact identifier rxcui: 1721583

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
5e81b4a7-b971-45e1-9c31-29cea8c87ce7	Tagrisso 80 MG Oral Tablet [PSN] · osimertinib 80 MG Oral Tablet [Tagrisso] [SBD] · Tagrisso 80 MG (as osimertinib mesylate 95.4 MG) Oral Tablet [SY]	3	36	These highlights do not include all the information needed to use TAGRISSO safely and effectively. See full prescribing information for TAGRISSO. TAGRISSO ® (osimertinib) tablets, for oral use Initial U.S. Approval: 2015	20240925